AHCC02
Find out about the AHCC 02 trial, a completed study testing Megestrol Acetate for inoperable liver cancer, and access its published results.
Trial summary of AHCC 02
AHCC 02 | Randomized Double Blind Trial of Megestrol Acetate Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma |
|---|---|
Status | Completed in 2007 with recruitment of 204 patients. Results published in Br J Cancer 2011 September 27;105(7): 945–952. |
Contributing Principal Investigators and Centres | Pierce Chow (SGH, Singapore), Khin Maung Win (Yangon, Myanmar), Soo Khee Chee (NCC, Singapore), Hoang Hoa Hai (Ho Chi Minh City, Vietnam), Nguyen Ba Duc (Hanoi, Vietnam), Jin Mo-Yang (Suwon, Korea), Rolley Lobo (Davao City, Philippines), M Findlay (Auckland, New Zealand) |
Protocol Chair | Pierce Chow |